Screener
Pfizer PFE Other Income (Expense)
Discontinued — last reported Q1 '24
Other Income (Expense) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Pfizer in its filing.
Tagged under the XBRL concept us-gaap:InterestRevenueExpenseNet.
The source filing: Pfizer’s 10-Q, filed May 8, 2024.
- Filed
- May 8, 2024
- Fiscal quarter
- Q1 FY2024
- Calendar quarter
- Q1 2024
- Accession
- 0000078003-24-000107
| Components of Other (income)/deductions––net include: / (MILLIONS) | Three Months Ended / March 31,2024 | April 2,2023 |
|---|---|---|
| Interest income | $(129) | $(177) |
| Interest expense | 790 | 318 |
| Net interest expense(a) | 661 | 141 |
| Net (gains)/losses recognized during the period on equity securities(b) | (25) | 451 |
| Income from collaborations, out-licensing arrangements and sales of compound/product rights | — | (68) |
| Net periodic benefit costs/(credits) other than service costs | (103) | (80) |
| Certain legal matters, net(c) | 208 | 36 |
| Certain asset impairments(d) | 109 | 264 |
Item 1.
FAQ
- What is Pfizer's other income (expense)?
- Pfizer (PFE) reported other income (expense) of -$661M in Q1 2024.
- How has Pfizer's other income (expense) changed year-over-year?
- Pfizer's other income (expense) decreased by 368.8% year-over-year, from -$141M to -$661M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Pfizer's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude